Xenetic Biosciences Inc. (XBIO)
4.12
0.01 (0.24%)
At close: Jan 15, 2025, 3:13 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -4.13M | -6.55M | -5.65M | -10.89M | -12.78M | -7.30M | -3.60M | -54.21M | -12.51M | -14.31M | -8.58M | -6.33M |
| Depreciation & Amortization | n/a | 27.04K | 35.48K | 28.84K | 27.49K | 15.83K | 23.78K | 36.45K | 56.12K | 88.69K | 52.03K | 104.62K |
| Stock-Based Compensation | 283.08K | 511.48K | 410.44K | 468.91K | 853.52K | 1.42M | 1.92M | 2.10M | 2.75M | 1.51M | 431.50K | 339.78K |
| Other Working Capital | 845.00 | -78.74K | 4.06K | 325.66K | -653.56K | -251.80K | 272.45K | -1.25M | 21.23K | n/a | 2.07M | -1.44M |
| Other Non-Cash Items | n/a | 1.79M | 24.27K | 9.10M | 3.03M | -5.23K | -126.32K | 49.11M | 834.00K | 239.89K | 431.50K | 51.16K |
| Deferred Income Tax | n/a | n/a | -24.27K | -2.92M | 3.34M | n/a | n/a | -1.58M | 2.60M | 639.67K | -446.47K | 1.05M |
| Change in Working Capital | -262.73K | -426.69K | 461.19K | -52.45K | -881.52K | -595.68K | 3.27M | -4.25M | 965.14K | -503.48K | 2.06M | -1.47M |
| Operating Cash Flow | -4.11M | -4.65M | -4.74M | -4.27M | -6.40M | -6.46M | 1.49M | -8.79M | -5.30M | -12.33M | -6.05M | -6.26M |
| Capital Expenditures | n/a | -500.00K | n/a | n/a | n/a | n/a | -9.26K | -16.79K | -1.66K | -57.67K | -78.63K | -130.08K |
| Acquisitions | n/a | -500.00K | n/a | n/a | 2.00K | 22.50K | n/a | n/a | 7.88K | 43.50K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 500.00K | n/a | n/a | 2.00K | 22.50K | n/a | n/a | 7.88K | -38.02K | -66.00K | 37.50K |
| Investing Cash Flow | n/a | -500.00K | n/a | n/a | 2.00K | 22.50K | -9.26K | -16.79K | 6.22K | -52.18K | -144.63K | -92.59K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.75M | 3.00M | n/a | n/a | -706.20K |
| Common Stock Repurchased | n/a | 1.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -16 | n/a | 3.68K | n/a | 6.21K | 1.48M | -125 | 8.97M | n/a | 9.82M | 2.09K | -18.31K |
| Financial Cash Flow | n/a | n/a | 11.45M | 5.43M | 16.13M | 1.48M | 125.00 | 12.72M | 3.00M | 9.82M | 2.09K | -303.35K |
| Net Cash Flow | -4.11M | -5.15M | 6.72M | 1.16M | 9.73M | -4.96M | 1.48M | 3.92M | -2.38M | -2.33M | -6.30M | -5.98M |
| Free Cash Flow | -4.11M | -5.15M | -4.74M | -4.27M | -6.40M | -6.46M | 1.48M | -8.80M | -5.30M | -12.39M | -6.13M | -6.39M |